Vancouver, B.C., June 18, 2025 – TheNewswire - Solarvest BioEnergy Inc. (“Solarvest” or the “Company”) (TSXV: SVS.H), a leading innovator in algal biologics and organic ingredient production, announces the appointment of Marc Buchman and Dr. Trevor Greenham to its Board of Directors, alongside the resignations of Grant Larsen, CEO, and Leslie Auld, CFO.

 

Marc Buchmann, has been appointed as the new CEO and a Director. He brings a proven track record in corporate strategy gained from thirty years of leadership experience in environment, technology and business innovation.

 

Dr. Trevor Greenham, PhD, has been appointed as a Director and Chief Science Officer of Solarvest BioEnergy Inc. He will investigate the R&D advancement of the company’s proprietary algae-based production platform.

 

Paul Lipoth and Alex MacKay remain as Directors of the Company.

 

The Board extends its sincere gratitude to Grant Larsen and Leslie Auld for their dedication and significant contributions to Solarvest, particularly in managing assets, assessing manufacturing and financial requirements, and initiating the process of restructuring the Company.

 

Solarvest remains committed to advancing its proprietary algal biologics platform which has included extensive work on its proprietary organic Omega-3 solution.

 

ABOUT SOLARVEST

 

Solarvest is a Canadian algal biologic research company with several unique patents in organic ingredient production with global commercial product applications.

 

For more information, please visit www.solarvest.com

 

For further information contact:

 

The Solarvest Bioenergy Board

Email: invest@solarvest.ca

 

Forward-Looking Statement

 

This news release includes forward-looking information and statements, which may include, but are not limited to, information and statements regarding or inferring the future business, operations, financial performance, prospects, and other plans, intentions, expectations, estimates, and beliefs of the Company. Forward-looking information and statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking information and statements herein. Although the Company believes that any forward-looking information and statements herein are reasonable, in light of the use of assumptions and the significant risks and uncertainties inherent in such information and statements, there can be no assurance that any such forward-looking information and statements will prove to be accurate, and accordingly readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance upon such forward-looking information and statements. Any forward-looking information and statements herein are made as of the date hereof, and except as required by applicable laws, the Company assumes no obligation and disclaims any intention to update or revise any forward-looking information and statements herein or to update the reasons that actual events or results could or do differ from those projected in any forward-looking information and statements herein, whether as a result of new information, future events or results, or otherwise, except as required by applicable laws.

 

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.